• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 1338

Brazzein preparation produced by a genetically engineered strain of Komagataella phaffii

Intended Use: Intended for use as a general-purpose sweetener in foods at levels consistent with current good manufacturing practices.
Basis: Scientific procedures
Notifier: SarvATGC Technologies Private Limited
Notifier Address: 7th Floor, SBR Gokulum Commercial
Whitefield-Hoskote Road, SH-35 Seegehalli
Bengaluru Karnataka - 560067
INDIA
GRAS Notice (releasable information): GRN 1338 (in PDF) (1.7 MB)
  Part 2: GRN 1338 amendments (in PDF) (1.2 MB)
Date of closure: Nov 4, 2026
FDA's Letter: FDA has no questions (in PDF) (177 kB)
-
-